StockData
Sonendo, Inc. logo

Sonendo, Inc. (SONX) stock

SONXOTCDental Equipment & SuppliesFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Mar 26, 2025
$1.28+0.00 (0.00%)

Close on Oct 19, 2026Market cap $606.54KP/E –Yield –

Sonendo, Inc. saw revenue fall 4.1% to $33.20M over the twelve months to Dec 31, 2024. Free cash flow was -$24.81M. At the latest close the market valued the company at $606.54K.

Revenue
$33.20M
-4.1% vs. a year earlier
Operating income
-$29.37M
TTM Q4 2024
Free cash flow
-$24.81M
TTM Q4 2024
EPS, diluted
-$59.03
TTM Q4 2024

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Dec 31, 2024

Valuation

Market cap
$606.54K
P/E ratio
–
Price to sales
0.02
Price to book
0.12
Dividend yield
–
Free cash flow yield
-4090.90%

Fundamentals

Revenue
$33.20M
Net income
-$28.03M
EPS, diluted
-$59.03
Free cash flow
-$24.81M
Book value per share
$10.95
Diluted shares
0M

Trading

Previous close
$1.28
Open
$1.28
Day's range
$1.28 – $1.28
Volume
0
Average volume (20 days)
1,144

Market cap history

Month-end market cap since 2021, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodSONXS&P 500DifferenceSONX per yearS&P 500 per year
1 month-1.5%+0.6%−2.2 pts
3 months+56.1%+3.4%+52.7 pts
Year to date+326.7%+13.3%+313.4 pts
1 year+212.2%+16.6%+195.6 pts
3 years-97.9%+86.4%−184.3 pts-72.4%+23.1%

Six years at a glance

Fiscal years 2019 to 2024, USD

Revenue

$33.20M-4.1% YoY

Gross profit

$11.84M+153.6% YoY

Operating income

-$29.37M

Net income

-$28.03M

EPS, diluted

-$59.03

Free cash flow

-$24.81M
Reported period

Press releases

Releases Sonendo filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Sonendo

Dental Equipment & Supplies

Sonendo, Inc. is a commercial-stage medical technology company that develops and manufactures medical devices designed to treat tooth decay and preserve tooth structure. Its principal offering is the GentleWave System, an FDA-cleared console and single-use procedure instrument platform that utilizes fluid optimization, broad-spectrum acoustic energy, and fluid dynamics for root canal therapy. The company operates through its Product segment, providing consoles and related accessories to dental practitioners, while having divested its Software practice management segment.

Company profile, executives and history

Sonendo stock: common questions

What is Sonendo's stock price?

SONX closed at $1.28 on Oct 19, 2026, up 0.00% on the day.

What is Sonendo's market cap?

Sonendo was worth $606.54K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is SONX's P/E ratio?

Sonendo lost money over the twelve months to Dec 31, 2024 (diluted EPS -$59.03), so it has no meaningful P/E ratio.

How much revenue does Sonendo make?

Sonendo reported revenue of $33.20M for the twelve months to Dec 31, 2024, down 4.1% from a year earlier.

Does Sonendo pay a dividend?

No. Sonendo has not paid a cash dividend over the last twelve months.

How has SONX stock performed over the past year?

Including dividends, SONX returned +212.2% over the past year, against +16.6% for the S&P 500.

Who are Sonendo's competitors?

Companies most similar to Sonendo by business, industry and size include SNWV, PROF, VVOS, IRIX, QTI.

See a number that looks wrong?